The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Explore recent insider activity at Aquestive Therapeutics (NYSE:AQST), ownership trends, and what they may indicate about the company's long-term outlook, corporate alignment, and market sentiment.

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Aquestive Therapeutics (AQST) one of those stocks right now? By taking a look at ...

Aquestive Therapeutics (AQST) reported $11.87 million in revenue for the quarter ended December 2024, representing a year-over-year decline of 10.2%. EPS of -$0.19 for the same period compares to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Study results for the sublingual administration of AQST-109 epinephrine oral film after consuming a peanut butter sandwich demonstrates consistent Tmax of 12 minutes Study results for swallowing ...

Aquestive Therapeutics (NASDAQ:AQST) is preparing to release its quarterly earnings on Wednesday, 2026-03-04. Here's a brief overview of what investors should keep in mind before the announcement.

It has been over six months since my previous Aquestive Therapeutics (AQST) article, where I discussed Anaphylm's potential approval and some of the possible catalysts along the way to their FDA PDUFA ...